Quantitative analysis of myo-inositol in urine, blood and nutritional supplements by high-performance liquid chromatography tandem mass spectrometry

J Chromatogr B Analyt Technol Biomed Life Sci. 2011 Sep 15;879(26):2759-63. doi: 10.1016/j.jchromb.2011.07.043. Epub 2011 Aug 6.

Abstract

Myo-inositol plays key physiological functions, necessitating development of methodology for quantification in biological matrices. Limitations of current mass spectrometry-based approaches include the need for a derivatisation step and/or sample clean-up. In addition, co-elution of glucose may cause ion suppression of myo-inositol signals, for example in blood or urine samples. We describe an HPLC-MS/MS method using a lead-form resin based column online to a triple quadrupole tandem mass spectrometer, which requires minimum sample preparation and no derivatisation. This method allows separation and selective detection of myo-inositol from other inositol stereoisomers. Importantly, inositol was also separated from hexose monosaccharides of the same molecular weight, including glucose, galactose, mannose and fructose. The inter- and intra-assay variability was determined for standard solutions and urine with inter-assay coefficient of variation (CV) of 1.1% and 3.5% respectively, while intra-assay CV was 2.3% and 3.6%. Urine and blood samples from normal individuals were analysed.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Chromatography, High Pressure Liquid / methods*
  • Dietary Supplements / analysis*
  • Glucose / metabolism
  • Humans
  • Inositol / analysis*
  • Inositol / blood
  • Inositol / urine
  • Linear Models
  • Reproducibility of Results
  • Sensitivity and Specificity
  • Stereoisomerism
  • Tandem Mass Spectrometry / methods*

Substances

  • Inositol
  • Glucose